I don't think people get it. These are adult stem cells they're using, no controversy, proven clinical track record, universal donor trials going great cutting down costs to the consumer when it goes commercial. Exposure to US market and Australian in heart conditions, broken bones, cartilage etc. Potential for dentistry, eyes, nothing wrong with this company, it will fly when it goes commercial.
Any estimate on that yet? I sort of estimated about mid to late 2009, that was about 6 months ago and for broken bones. Any other estimates?
notice received, page-7
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.105(8.37%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.23 | $1.14 | $9.583M | 8.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |